Kapat
Popüler Videolar
Moods
Türler
English
Türkçe
Popüler Videolar
Moods
Türler
Turkish
English
Türkçe
Best Practices for Proprietary Name Design – Pharmacovigilance 2020
46:22
|
Loading...
Download
Lütfen bekleyiniz...
Type
Size
İlgili Videolar
Best Practices for Proprietary Name Design – Pharmacovigilance 2020
46:22
|
Process for Reviewing Nonproprietary Name Suffix for Biological Products – Pharmacovigilance 2020
22:45
|
Nonproprietary Name Suffix and Safety for Product Design and Labels (10of15) REdI – May 29-30, 2019
40:08
|
Designing User Interfaces to Prevent Medication Errors – Pharmacovigilance 2020
47:15
|
ICSR Data Quality of Coding: Products, Adverse Events and Medication Errors - Pharmacovigilance 2020
34:57
|
Questions and Discussion – Pharmacovigilance 2020
5:52
|
Keynote – Pharmacovigilance and Risk Management Conference 2020
30:38
|
Division of Risk Management: Overview of Review Activities and REMS - Pharmacovigilance 2020
41:06
|
Meetings: Pre-submission and Special Programs (4of15) REdI Annual Conference – May 29-30, 2019
41:30
|
FDA's Sentinel Initiative - Pharmacovigilance 2020
54:27
|
Preventing Medication Errors: Lessons Learned from Postmarket Safety Surveillance– Pharmacovigilance
29:21
|
CDER FDA Exclusivity – Which One Is for Me? - June 10, 2019
1:00:50
|
FDA Adverse Event Reporting System (FAERS) Overview - Pharmacovigilance 2020
48:21
|
Labeling for Biological Products (11of19) PDL – Dec.4-5, 2019
27:45
|
Development of Shared System REMS & Implications of the Appropriations Act - Pharmacovigilance 2020
42:22
|
Simplifying the 2023 FDA Guidance on Human Factors Engineering Principles for Combination Products
4:18
|
FDA's Role in Drug Development 7 30 19 Webinar
59:59
|
Combination Products: Reporting Device Information and Malfunctions - Pharmacovigilance 2020
23:33
|
Regulatory Highlights for Biosimilars and Interchangeables (9of15) REdI – May 29-30, 2019
42:43
|
SME Assist: Post market monitoring
14:55
|
Copyright. All rights reserved © 2025
Rosebank, Johannesburg, South Africa
